Scream Cream Rx'Scream cream'

Scream Cream Rx / Evidence

Scream Cream Rx human studies: what the evidence shows

Last updated 2026-07-27

TL;DR

There are no published clinical trials of "Scream Cream Rx" as a branded product. Small studies exist on its common ingredients, mainly topical sildenafil and L-arginine, for female sexual arousal disorder, and results are mixed and mostly underpowered. The FDA has approved zero topical arousal creams; Addyi and Vyleesi treat low desire, not local arousal, and work differently.

Has Scream Cream itself been studied in humans?

No. There is no published, peer-reviewed clinical trial that tests a product called "Scream Cream" or "Scream Cream Rx" as a defined, fixed formula. That's the first thing to get straight before reading anything else on this page. What exists instead is a scattering of small studies on individual ingredients that commonly show up in compounded arousal creams, mostly topical sildenafil, L-arginine, and sometimes combinations with alprostadil or testosterone. Compounding pharmacies build their own versions of "scream cream" using a mix of these, and the recipe is not standardized across pharmacies or prescribers. Two women with prescriptions from two different clinics can legally receive two different products, both marketed under the same nickname [1]. That matters for how you read any "evidence" claim online. When a website says "clinical studies show scream cream increases arousal," ask which ingredient, at what concentration, tested in what population, published where. Usually the answer is vague, because the compounded product as a whole has never gone through the kind of controlled trial the FDA requires for approval.

What does the research say about topical sildenafil for women?

The evidence is thin and inconsistent. Sildenafil (the active drug in Viagra) works in men by increasing blood flow through a well-characterized pathway involving nitric oxide and PDE5 inhibition. In theory, a topical version applied to genital tissue could increase local blood flow in women too, but women's sexual arousal problems are often more about desire, hormones, and psychological factors than about blood flow alone, which is a big part of why results have been underwhelming. A frequently cited pilot study by Ferguson et al. (2003), published in the Journal of Sex & Marital Therapy, tested a topical alprostadil cream (not sildenafil) on women with female sexual arousal disorder and found modest improvement in some subjective arousal measures compared to placebo, but the sample was small and the effect size limited [2]. Earlier oral sildenafil trials in women, such as the study by Basson et al. published in Obstetrics & Gynecology (2002), found no significant benefit over placebo for women with sexual arousal disorder without a comorbid erectile-type vascular problem [3]. That's oral, not topical, but it's one of the better-controlled trials in this space and it's a caution sign for the whole PDE5-inhibitor-for-women approach. I have not found a peer-reviewed, placebo-controlled human trial specifically testing a topical sildenafil cream formulated the way compounding pharmacies typically make "scream cream" (sildenafil plus L-arginine, often with other agents). If you find one cited somewhere, check the journal and the sample size before trusting it. Most of what circulates online traces back to these older, small, mixed-result studies on related but not identical formulations.

What about L-arginine, the other common ingredient?

L-arginine is an amino acid that the body converts into nitric oxide, which relaxes blood vessels. The theory for including it in arousal creams is the same as for sildenafil: more blood flow to genital tissue, more physical arousal sensation. Human data on oral L-arginine combined with yohimbine for female sexual arousal disorder exists, including a small double-blind, placebo-controlled study by Meston and Worcel published in the Archives of Sexual Behavior (2002), which found the combination improved some measures of physiological arousal in postmenopausal women compared to placebo [4]. But that's an oral combination, not a topical cream, and yohimbine carries its own cardiovascular risks and isn't a standard ingredient in most compounded scream creams sold today. Topical L-arginine alone, at the concentrations compounding pharmacies typically use, doesn't have a solid independent trial record for genital arousal that I can point to. It's plausible mechanistically. It isn't proven.

How does this compare to Addyi and Vyleesi, the two FDA-approved options?

This is where the contrast gets useful. Addyi (flibanserin) and Vyleesi (bremelanotide) are the only two FDA-approved prescription treatments for a female sexual dysfunction, and both target hypoactive sexual desire disorder (HSDD), not local genital arousal. Neither is a topical cream. Addyi is a daily oral pill; Vyleesi is a self-injected pen used as needed before sexual activity. Addyi's approval was based on trials showing an average increase of about 0.5 to 1 additional "satisfying sexual event" per month compared to placebo, a modest effect that came with a boxed warning about severe low blood pressure and fainting when combined with alcohol [5]. Vyleesi's trials, described in its FDA label, showed roughly 25% of women reported a meaningful improvement in desire versus about 17% on placebo, again a real but not dramatic difference, alongside common side effects of nausea (reported in about 40% of users) and flushing [6]. Neither drug is FDA-approved for arousal in the physical, blood-flow sense that topical scream cream targets. That's a real and useful distinction: Addyi and Vyleesi work on brain chemistry tied to desire; compounded topical creams aim at local tissue response. Both categories have limited efficacy data. Neither is a slam dunk. But at least Addyi and Vyleesi went through FDA-mandated Phase 3 trials with published results; compounded scream cream has not.

Why hasn't scream cream gone through FDA trials?

Because it's compounded, not manufactured. Compounded drugs are prepared by a licensed pharmacy for an individual patient's prescription, under a framework the FDA regulates differently from mass-manufactured drugs. Section 503A of the Federal Food, Drug, and Cosmetic Act allows compounding pharmacies to prepare customized medications without going through the new-drug approval process, as long as they compound based on a valid prescription and don't compound commercially available products in bulk . That framework exists for good reasons, like letting a pharmacist adjust a dose for a patient who can't take a standard tablet. But it also means compounded products, including every version of scream cream on the market, never have to prove safety and efficacy in controlled trials the way an FDA-approved drug does. The FDA's own guidance is direct about this gap: compounded drugs "have not been proven safe and effective by the FDA" . No company owns a patent on "scream cream" and no company has an incentive to fund a multi-million-dollar Phase 3 trial for a compounded mixture that any pharmacy can make once a doctor writes the script. That's the honest economic reason there's no big definitive study sitting in a drawer somewhere.

What did the actual small studies find, in plain numbers?

Ferguson et al., 2003, J Sex Marital Ther [2]Topical alprostadil creamSmall placebo-controlled pilotModest improvement in some subjective arousal scores vs. placebo
Basson et al., 2002, Obstet Gynecol [3]Oral sildenafilRandomized, placebo-controlledNo significant benefit over placebo in women without comorbid vascular arousal disorder
Meston & Worcel, 2002, Arch Sex Behav [4]Oral L-arginine + yohimbineSmall double-blind, placebo-controlledImproved some physiological arousal measures in postmenopausal women
Addyi Phase 3 trials (FDA label) [5]Flibanserin (oral, desire-focused)Randomized, placebo-controlled, large N~0.5-1 more satisfying sexual event/month vs. placebo
Vyleesi Phase 3 trials (FDA label) [6]Bremelanotide (injectable, desire-focused)Randomized, placebo-controlled, large N~25% meaningful response vs. ~17% placeboThe pattern across the row is small samples, modest effects, and nothing that tests the actual multi-ingredient compounded cream women are prescribed today.

Here's a side-by-side of the closest published human data, none of which tested a branded scream cream product directly. | Study | Ingredient tested | Design | Result |

What the closest human studies actually found No trial tests the compounded scream cream formula directly; these are the nearest related findings 0.8 Addyi: extra satisfying sex… events/month vs placebo 25 Vyleesi: meaningful respons… vs placebo (%) 17 Vyleesi placebo response ra… (%) 40 Vyleesi nausea rate reported (%) Source: FDA drug labels; PubMed-indexed studies, 2002-2003

Why do formulas vary so much between pharmacies?

Because there's no single approved recipe. "Scream cream" is a nickname, not a formula. One compounding pharmacy might mix sildenafil at 2% with L-arginine; another might add testosterone, minoxidil, or aminophylline; concentrations can differ by a factor of two or more between pharmacies with no regulatory requirement that they match . This is the single biggest reason to be skeptical of any blanket claim that "scream cream works" or "scream cream is safe." The version your prescriber sends to Pharmacy A may not resemble the version a different prescriber sends to Pharmacy B, in dose, in ingredient list, or in vehicle base. If you're comparing notes with a friend who used scream cream, you may literally be discussing two different drugs. This is also why picking a provider who reviews your history and a pharmacy with a track record matters more here than with a standardized, FDA-approved drug. Ask your prescriber to name the exact ingredients and concentrations in writing before you fill anything, and check what to expect around how to reconstitute Scream Cream Rx if your version requires mixing, since compounded topicals aren't always ready-to-use out of the vial.

Is compounded scream cream legal and regulated at all?

Yes, but under a lighter regulatory bar than approved drugs. Compounding pharmacies operate under FDA's Section 503A framework and are also subject to state pharmacy board oversight, which varies by state . The FDA explicitly does not verify the safety, effectiveness, or quality of individual compounded preparations before they reach patients, unlike its premarket review process for approved drugs like Addyi and Vyleesi. That doesn't mean it's a black market. A legitimate compounding pharmacy filling a valid prescription from a licensed prescriber is operating within the law. It means the burden of quality control sits more heavily on the individual pharmacy's practices (sterility, accurate concentration, proper storage) rather than on a standardized FDA-audited manufacturing line. This is part of why the fulfilling pharmacy partner matters, more than the prescriber.

What are the known or likely side effects, given the ingredients?

Because there's no dedicated trial of the compounded product, side effect data has to be extrapolated from the individual ingredients, which is imperfect but the best information available. Topical sildenafil could theoretically cause local irritation, warmth, or flushing at the application site; systemic absorption is thought to be lower than with an oral dose but isn't zero, and doesn't have solid dose-response data in women published anywhere I could find. Oral PDE5 inhibitor side effects in men (headache, flushing, nasal congestion) give a rough sense of what systemic exposure could look like if enough of the topical dose is absorbed. L-arginine at oral doses has been linked to gastrointestinal upset in some studies; topical use at compounded doses doesn't have equivalent published safety data. If a compounded formula includes other agents like testosterone or additional vasodilators, the side effect profile shifts again and depends entirely on what's actually in the jar. For a fuller rundown of what users report and what's biologically plausible given typical ingredients, see Scream Cream Rx side effects. If you're on nitrates, have uncontrolled low blood pressure, or are pregnant or breastfeeding, talk to your prescriber before starting, given sildenafil's known interactions in other formulations.

Should you trust marketing claims that cite 'clinical studies'?

Treat any unqualified claim that scream cream is proven to work with real skepticism. Ask three questions: which specific ingredient and concentration was tested, was the study placebo-controlled and peer-reviewed, and does the sample size support the claim being made (a study of 20 women is not the same evidence base as a Phase 3 FDA trial with hundreds of participants). When a marketing page cites a study, look it up yourself if you can. The gap between "a small pilot study found modest improvement in one subjective measure" and a blanket claim of proven efficacy is exactly the gap that gets papered over in sales copy. A provider-reviewed source should be willing to name the actual ingredients in your specific formula and point you to what's known, and not known, about them, rather than leaning on the word "clinical" as a stand-in for evidence.

What should you actually expect if you try it?

Expect a legally compounded, individually prescribed product with an ingredient list that should be disclosed to you in writing, not a proven, standardized, FDA-approved drug with trial data behind it. Some women report subjective improvement in sensation or lubrication; that's consistent with the modest, mixed findings in the small studies above, but it isn't something a controlled trial has confirmed for the compounded product itself. Dosing, timing before sexual activity, and cycle length all depend on the specific formula your prescriber sends, which is another reason a fixed answer doesn't exist site-wide; see Scream Cream Rx cycle length and Scream Cream Rx half life for what's known about timing given typical sildenafil pharmacokinetics. Store it properly too; compounded topicals can degrade faster than manufactured drugs, covered in Scream Cream Rx storage and shelf life. If you want to move forward, Scream Cream Rx's provider-reviewed process connects you with a licensed prescriber who reviews your health history before anything is sent to a compounding pharmacy partner for fulfillment, which is a meaningfully different starting point than ordering an unreviewed jar off a generic website.

Frequently asked questions

Is there a published clinical trial on Scream Cream specifically?

No. No peer-reviewed trial has tested a product called Scream Cream Rx by name. The evidence that exists covers individual ingredients like topical sildenafil, alprostadil, and L-arginine tested separately, in small studies, with mixed results. None replicate the exact multi-ingredient compounded formula a specific pharmacy might send you.

Does the FDA approve scream cream?

No. The FDA has not approved any topical compounded arousal cream. Compounded drugs, including scream cream, are prepared under Section 503A of the Food, Drug and Cosmetic Act for individual prescriptions and are not required to go through the FDA's new-drug safety and efficacy trials.

What's the difference between scream cream and Addyi or Vyleesi?

Addyi and Vyleesi are FDA-approved, target low sexual desire (not local arousal), and went through Phase 3 trials. Scream cream is a compounded topical, usually sildenafil plus L-arginine, aimed at local blood flow and physical arousal, and has no FDA approval or dedicated large-scale trial.

Does topical sildenafil actually work for women?

The data is limited and inconsistent. A 2002 randomized trial by Basson et al. in Obstetrics & Gynecology found oral sildenafil gave no significant benefit over placebo for women with arousal disorder without a comorbid vascular condition. No large, published trial confirms efficacy for the topical version specifically.

What ingredients are typically in scream cream?

Most commonly sildenafil and L-arginine, sometimes combined with testosterone, aminophylline, or other vasodilators depending on the compounding pharmacy and prescriber. There's no single standard formula or concentration; recipes vary by pharmacy, which is why the exact ingredient list on your prescription matters more than the nickname.

Is scream cream safe?

There's no dedicated safety trial of the compounded product. Safety data has to be inferred from individual ingredients, which suggests local irritation or flushing are plausible but systemic risk depends on absorption and formula. People on nitrates or with uncontrolled low blood pressure should talk to a prescriber first given sildenafil's known interactions.

Why isn't scream cream FDA-approved if it's been around for years?

Because it's compounded, not manufactured. Compounding pharmacies can legally prepare it for individual patients under FDA's Section 503A framework without running it through new-drug trials. There's also no financial incentive for a company to fund an expensive Phase 3 trial for a formula any compounding pharmacy can replicate once a doctor prescribes it.

Can two pharmacies' scream cream be different products?

Yes, functionally. Ingredient lists, concentrations, and inactive bases can all differ between compounding pharmacies since there's no standardized formula. A prescription from one clinic filled at one pharmacy may not match a prescription from a different clinic filled elsewhere, even under the same nickname.

What did the closest real study on a related ingredient find?

Ferguson et al. (2003, Journal of Sex & Marital Therapy) tested topical alprostadil cream in a small placebo-controlled pilot and found modest improvement in some subjective arousal measures. It didn't test sildenafil or the typical scream cream combination, and the sample was small enough that it can't be read as strong proof.

How is Vyleesi different from a topical cream like scream cream?

Vyleesi (bremelanotide) is an FDA-approved, self-injected pen used before sexual activity that acts on brain melanocortin receptors to affect desire. It's systemic, not local, and its Phase 3 trials showed about 25% of users had a meaningful desire response versus about 17% on placebo.

Should I ask my prescriber what's in my specific formula?

Yes. Because formulas and concentrations vary by compounding pharmacy, ask for the exact ingredient list and strength in writing before filling. This lets you check known interactions, plan around any nitrate medications, and compare what you're getting against the limited published research on each individual ingredient.

Are there side effects reported with L-arginine creams?

Oral L-arginine has been linked to gastrointestinal upset in some studies, including the Meston and Worcel (2002) trial combining it with yohimbine. Topical use at the doses compounding pharmacies typically use doesn't have equivalent published safety data, so most of what's known is extrapolated rather than directly studied.

Sources

  1. Ferguson et al., Journal of Sex & Marital Therapy, 2003: Small placebo-controlled pilot on topical alprostadil cream found modest improvement in subjective arousal measures
  2. Basson et al., Obstetrics & Gynecology, 2002: Randomized trial found oral sildenafil gave no significant benefit over placebo in women without comorbid vascular arousal disorder
  3. Meston & Worcel, Archives of Sexual Behavior, 2002: Small double-blind trial of oral L-arginine plus yohimbine improved some physiological arousal measures in postmenopausal women
  4. FDA, Vyleesi (bremelanotide) prescribing information: Vyleesi Phase 3 trials showed about 25% meaningful response versus about 17% on placebo, with nausea reported in about 40% of users
  5. 21 U.S.C. 353a, Federal Food, Drug, and Cosmetic Act, Section 503A (Pharmacy compounding): Section 503A allows compounding pharmacies to prepare customized medications for individual patients without going through the new-drug approval process, based on a valid prescription
  6. FDA, "Human Drug Compounding" guidance page: FDA guidance states that compounded drugs have not been proven safe and effective by the FDA